Gastrointestinal varices epidemiology and demographics

Jump to navigation Jump to search

Gastrointestinal varices Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gastrointestinal varices from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Gastrointestinal varices epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastrointestinal varices epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastrointestinal varices epidemiology and demographics

CDC on Gastrointestinal varices epidemiology and demographics

Gastrointestinal varices epidemiology and demographics in the news

Blogs on Gastrointestinal varices epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Gastrointestinal varices epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Gastroesophageal varices are present in approximately 50,000 per 100,000 patients with cirrhosis, depending upon the clinical stage of the disease. The annual incidence of gastrointestinal varices ranges from a low of 7,000 per 100,000 individuals to a high of 8,000 per 100,000 individuals. Variceal hemorrhage occurs at a rate of around 10%-15% per year and depends on the severity of liver disease, size of varices, and presence of red wale marks (areas of thinning of the variceal wall).

Epidemiology and Demographics

Prevalence

  • Gastroesophageal varices are present in approximately 50,000 per 100,000 patients with cirrhosis, depending upon the clinical stage of the disease[1]
  • In patients with compensated cirrhosis, gastroesophageal varices are present in 30,000 - 40,000 patients per 100,000 patients, whereas they can be present in up to 85,000 per 100,000 patients with decompensated cirrhosis[2]

Incidence

  • The annual incidence of gastrointestinal varices ranges from a low of 7,000 per 100,000 individuals to a high of 8,000 per 100,000 individuals[3]
  • Progression from small varices to large varices occurs at a rate of 10%- 12% annually[4]
  • Variceal hemorrhage occurs at a rate of around 10%-15% per year and depends on the severity of liver disease, size of varices, and presence of red wale marks (areas of thinning of the variceal wall)[5][6]

Age

  • African Americans are significantly more likely to be older than Caucasians or Hispanics, when patients with cirrhosis are studied[7]
  • White patients have equal proportions of cirrhotics in the younger and older age groups[8]

Race

  • Hispanic and White patients were more likely to have cirrhosis due to alcohol than African American patients[9]
  • The prevalence of HCV appears to be the greatest in African American patients, compared to all other ethnic groups in the United States[10]

References

  1. "Portal hypertension and variceal bleeding: An AASLD single topic symposium - Grace - 2003 - Hepatology - Wiley Online Library".
  2. Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A (2007). "Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database". Gastrointest. Endosc. 65 (1): 82–8. doi:10.1016/j.gie.2006.08.023. PMID 17185084.
  3. Groszmann, Roberto J.; Garcia-Tsao, Guadalupe; Bosch, Jaime; Grace, Norman D.; Burroughs, Andrew K.; Planas, Ramon; Escorsell, Angels; Garcia-Pagan, Juan Carlos; Patch, David; Matloff, Daniel S.; Gao, Hong; Makuch, Robert (2005). "Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis". New England Journal of Medicine. 353 (21): 2254–2261. doi:10.1056/NEJMoa044456. ISSN 0028-4793.
  4. Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, Riggio O (2003). "Incidence and natural history of small esophageal varices in cirrhotic patients". J. Hepatol. 38 (3): 266–72. PMID 12586291.
  5. "Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study". N. Engl. J. Med. 319 (15): 983–9. 1988. doi:10.1056/NEJM198810133191505. PMID 3262200.
  6. D'Amico G, Pagliaro L, Bosch J (1999). "Pharmacological treatment of portal hypertension: an evidence-based approach". Semin. Liver Dis. 19 (4): 475–505. doi:10.1055/s-2007-1007133. PMID 10643630.
  7. Pearlman BL (2006). "Hepatitis C virus infection in African Americans". Clin. Infect. Dis. 42 (1): 82–91. doi:10.1086/498512. PMID 16323096.
  8. Sajja KC, Mohan DP, Rockey DC (2014). "Age and ethnicity in cirrhosis". J. Investig. Med. 62 (7): 920–6. doi:10.1097/JIM.0000000000000106. PMC 4172494. PMID 25203153.
  9. Sajja KC, Mohan DP, Rockey DC (2014). "Age and ethnicity in cirrhosis". J. Investig. Med. 62 (7): 920–6. doi:10.1097/JIM.0000000000000106. PMC 4172494. PMID 25203153.
  10. Pearlman BL (2006). "Hepatitis C virus infection in African Americans". Clin. Infect. Dis. 42 (1): 82–91. doi:10.1086/498512. PMID 16323096.